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A B S T R A C T 
 
 
In this study the effect of oxidative modification on micellar and drug delivery 
properties of copolymers of ethylene oxide (EO) and propylene oxide (PO) was 
investigated. Carboxylated trifunctional copolymers were synthesized in the reaction with 
chromium oxide (VI). We found that carboxylation significantly improved the uniformity 
and stability of polymeric micelles by inhibiting the microphase transition. The 
cytotoxicity of copolymers was studied in relation to their aggregative state on two cell 
types (cancer line vs. primary fibroblasts). The accumulation of rhodamine 123 in 
neuroblastoma SH-SY5Y cells was dramatically increased in the presence of the oxidized 
block copolymer with the number of PO and EO units of 83.5 and 24.2, respectively. The 
copolymer was also tested as an enhancer for topical drug delivery to the spinal cord 
when  applied  subdurally.  The  oxidized  copolymer  facilitated  the  penetration  of 
rhodamine 123 across spinal cord tissues and increased its intraspinal accumulation. 
These results show the potential of using oxidized EO/PO based polymers for non- 
invasive delivery of protective drugs after spinal cord injury. 
 
Keywords: Amphiphilic polymers; Trifunctional copolymers of ethylene oxide and 
propylene oxide; Oxidative modification; Micelles; Drug delivery; Neural cells; Spinal 
cord; Traumatic injury 
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1. Introduction 
 
 
Although a number of synthetic and biological substances were suggested as 
neuroprotectors, there is still a lack of available therapy for neurotrauma and particularly 
for spinal cord (SC) injury [1]. The only clinically accepted substance to cure the acute 
spinal cord injury is high-dose intravenous infusion of methylprednisolone, which is 
nevertheless controversial and related with serious side effects [2]. 
A line of potential agents with the neuroprotective activity has been studied over the 
last years, such as antioxidants [3], antagonists for glutamate excitotoxicity [4], and 
others. Recently polymers and colloids attract interest of researchers as promising 
neuroprotective agents and also a system for drug delivery. 
Borgens et al. demonstrated that the administration of low molecular weight PEG to 
guinea pigs after severe spinal cord injury results in a significant recovery of nerve 
conduction and inhibition of consequences of secondary trauma [5,6]. Several 
mechanisms for PEG-assisted neuroprotection have been proposed, including direct 
sealing of the plasma membrane of damaged nerve cells, inhibition of calcium influx and 
oxidative stress, mitochondria protection and apoptosis inhibition [5,6]. The polymer- 
based therapy has been extended to PEG-related amphiphilic polymers, e.g. the block 
copolymer of ethylene oxide (EO) and propylene oxide (PO) Pluronic F68 (Poloxamer 
188) [7] and PEG–polylactic acid (PLA) copolymer [8], which exhibited neuroprotective 
effect in SC injury at lower dose than that for PEG. 
Other approaches to treating SC injury have been focused on the local polymer- 
assisted transfer of bioactive substances to the damaged spinal cord. Most studies in this 
field have reported gel and nanoparticle-based formulations with encapsulated drugs, 
which are intrathecally injected in the SC. Gupta et al. proposed fast-gelling 
hyaluronan/methylcellulose composite which exhibited biocompatible properties upon 
prolonged implantation in the SC [9]. Kim et al. developed methylprednisolone-loaded 
poly(lactic-co-glycolic acid) nanoparticles prepared by the double emulsion method. The 
local injection of nanoparticles in the SC helps to prolong drug delivery in a more 
effective compared to systemic administration way [10]. 
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Furthermore, photoactivated biodegradable hydrogel synthesized from acrylated PLA– 
PEG–PLA block copolymer has been proposed by Piantino et al. as an injectable 
formulation releasing the trophic factor neurotrophin-3 to promote the axonal growth and 
functional recovery of damaged spinal nerves [11]. Recently, polyacrylate/agarose 
composite hydrogels, containing poly(methyl methacrylate) nanoparticles, with different 
porosity were developed for the sustained and controllable release of both small-molecule 
drugs and nanoparticles. Drug-releasing properties of these hydrogels were also studied 
after their intrathecal injection in mouse spinal cord [12]. 
Compared with invasive injections of polymeric systems, the topical drug delivery 
across SC membranes is expected to be safer, however it requires appropriate enhancers 
for drugs transport to the site of injury. Except of relatively toxic dimethyl sulfoxide 
vehicle [13], to this time no safe and effective enhancers have been proposed for drug 
delivery to the SC. 
Micelle-forming non-ionic amphiphilic polymers are one of the most promising 
delivery systems for anticancer and CNS-directed drugs. Among them, systematically 
studied bifunctional (EO)x–(PO)y–(EO)x block copolymers, Pluronics®, have been shown 
to modulate functional activity of cellular membranes and increase their permeability to 
different drugs [14]. Other amphiphilic polymers, including non-ionic PEG–PLA [15], 
charged quaternised poly(propylene imine) dendrimer [16] and thioglycolic acid- 
modified methoxy PEG-b-poly(5-allyloxy-1,3-dioxan-2-one) [17] were recently proposed 
as micellar carriers for anticancer and anti-inflammatory compounds. 
We demonstrated previously that the introduction of anionic groups into EO/PO 
copolymers [18] and the use of their tri-functional glycerol-based analogs, exhibiting 
structural similarity to membrane lipids [19], are promising approaches to developing 
safe and potent polymeric carriers and enhancers. In this study, chemically oxidized 
trifunctional copolymers of EO and PO with improved micellar properties were 
synthesized. Our findings demonstrate for the first time that the oxidized copolymers can 
enhance topical drug delivery to the spinal cord. 
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2. Experimental 
 
 
2.1. Reagents and materials 
 
 
Trifunctional copolymers of PO and EO (Laprol® 5003, Laprol® 6003, structural 
analogs of Voranols, Dow Chemical) were produced by JSC Nizhnekamskneftekhim 
(Russia). Pluronic block copolymers of PO and EO (Pluronic® L61, Pluronic® F68) 
were produced by Sigma-Aldrich. 
Polyacrylic acid (Carbopol 934) was produced by Serva. Chromium oxide (VI), p- 
formaldehyde, glutaraldehyde (25 % solution), pyrene, chloral hydrate, organic solvents 
and inorganic salts were purchased from Acros Organics. Rhodamine 123, 4',6- 
diamidino-2-phenylindole (DAPI) and (3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium  bromide)  (MTT)  were  purchased  from  Sigma-Aldrich.  Neg-50 
frozen section medium was purchased from Thermo Scientific. 
Cell culture reagents were purchased from PAA Laboratories. 
 
 
 
2.2. Synthesis and characterization of oxidized copolymers 
 
 
Copolymers of EO and PO were oxidized by CrO3  according to previously proposed 
method for PEGs [20]. Briefly, the copolymer (5–15 g) was mixed with CrO3 at a ratio of 
1 : 3 by mole in 25 % solution of sulfuric acid. The mixture was incubated for 24 hrs 
under constant stirring. The product was extracted with a double volume of 
dichloromethane (×3), and washed with 1/10 volume of water (×2) and 1/10 volume of 
saturated sodium chloride solution (×1). The extract was dehydrated under anhydrous 
magnesium sulfate and dried on a rotary evaporator. The products were oily substances 
with yellowish color. The yield was 65 and 67 % for modified Laprol 5003 and Laprol 
6003, respectively. 
 
The presence of carboxyl groups in modified copolymers were verified by a FTIR 
spectroscopy on a Frontier spectrometer (Perkin Elmer) using the following parameters: 
wavenumber region 4000–400 cm-1, resolution 1 cm-1, scan number 64. The modification 
extent was determined by means of acid-base titration with 0.01 M potassium hydroxide 
as a titrant and Nile blue as a pH indicator. Complete conversion of three terminal 
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hydroxyls in trifunctional copolymers into carboxyl groups was assumed equal to 100 % 
 
modification. 
 
 
 
2.3. High-performance liquid chromatography 
 
 
Chromatographic analysis of integrity of oxidized copolymers was carried out on an 
Ultimate 3000 HPLC system (Dionex / Thermo Fisher Scientific). Copolymers dissolved 
in HPLC-grade methanol were separated on a Zorbax SB-C18 column with dimensions 
4.6×150 mm and pore size of 80 Å (Agilent). The isocratic mode was used with the 
following parameters: methanol / water (40 / 60) mobile phase; flow rate 0.5 mL/min; 
UV-detector 220 nm. Chromatographic data acquisition and processing was performed 
with the aid of Chromeleon 6.80 software. 
 
 
2.4. Study of micelle-forming properties of oxidized copolymers 
 
 
The critical micellar concentration (CMC) of copolymers was determined with the use 
of pyrene probe in PBS at room temperature as described in [18]. Copolymer aggregates 
were further analyzed by the dynamic light scattering (DLS) technique on a Zetasizer 
Nano ZS instrument (Malvern Instruments). Hydrodynamic diameter and zeta potential 
were registered in 50 mM HEPES buffer (pH 7.0) or in DMEM with 5 % fetal bovine 
serum at copolymer concentrations of 0.2 and 2 mg/mL, respectively. The measurements 
were performed in triplicates. 
 
 
2.5. Cell culturing 
 
 
Primary human skin fibroblasts (HSFs) were isolated from skin explants according to a 
conventional procedure [21]. Human neuroblastoma SH-SY5Y cells were obtained from 
ATCC. HSFs were cultured in α-MEM supplemented with 10 % FBS, 2 mM L- 
glutamine, 100 μg/mL streptomycin and 100 U/mL penicillin under standard conditions 
(37 °C, humidified atmosphere of 5 % CO2). SH-SY5Y cells were grown in the same 
conditions, but in DMEM medium. 
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2.6. MTT-assay 
 
 
Cytotoxic concentrations (IC50) of copolymers were determined with the use of MTT 
assay. Cells were pre-seeded in 96-well plate at the density of 1000 cells per well and 
cultured with adding serially diluted copolymer solutions under standard conditions. 
After 3 day culturing, the medium was replaced by the fresh one supplemented with 0.5 
mg/mL MTT reagent, which was further kept for 4 hrs to reduce MTT into colored 
formazan by viable cells. Optical absorption of formazan, proportional to the number of 
viable cells, was registered on Infinite M200 PRO analyzer (Tecan) at the wavelength of 
550 nm. 
 
 
 
2.7. Study of rhodamine 123 accumulation in SH-SY5Y cells 
 
 
SH-SY5Y cells were collected and suspended in PBS at a density of 1.5×10
6 
cells/mL. 
An aliquot of the copolymer solution was added to the cell suspension in 1.5 mL 
polystyrene tubes to obtain final concentration of 1 mg/mL. After 15 min pre-incubation 
with a copolymer, the cell suspension was supplemented with 5 μM rhodamine 123 and 
additionally kept for 30 min at 37 °C under mild agitation. The treated cells were washed 
twice with chilled PBS by means of centrifugation and lysed in 1 mg/mL Triton X100 in 
deionized water solution. Cell lysates were then transferred into 96-well plates, followed 
by the detection of rhodamine 123 fluorescence on Infinite M200 PRO analyzer at λex 
480 nm and λem 530 nm. 
 
 
 
2.8. Preparation of topical gel formulation 
 
 
Polyacrylic acid was solubilized and neutralized with sodium hydroxide to obtain 4 
wt% viscous gel (pH 7.0). The gel was further mixed with equally amount of 1 wt% 
copolymer solution in PBS containing 100 μM rhodamine 123 to produce the topical gel 
formulation  containing  2  wt%  polyacrylate,  0.5  wt%  L6–COOH  as  a  penetration 
enhancer and 50 μM rhodamine 123 as a delivered compound. 
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2.9. Topical delivery of rhodamine 123 to rat spinal cord 
 
 
Eight adult male Wistar rats (250–400 g) were used for in vivo study. Animal care was 
performed according to European regulations on the protection of experimental animals 
(Directive 2010/63/UE) and current Russian regulations (No.742 from 13.11.1984, 
(Ministry of Education and Science). The study was approved by the Ethic committee of 
Kazan Federal University (Russia). 
All surgical procedures were carried out under aseptic conditions. Rats were 
anesthetized deeply using isoflurane inhalation. Laminectomy was performed at Th13 
vertebral segment and the dura mater was cut to expose the spinal cord (SC). Both 
control and experimental groups included four animals. Polyacrylate gels loaded with 
rhodamine 123 (control group) or rhodamine 123/copolymer mixture (experimental 
group) were accurately applied onto the arachnoid membrane of SC using insulin syringe 
(100 μL gel aliquot per segment) and kept for 2 hrs. After exposure the gel was washed 
out with PBS. Animals were additionally narcotized by the intraperitoneal injection of 
chloral hydrate at a dose of 300 mg/kg and subjected to a conventional transcardial 
perfusion with 4 % formalin in PBS (500 mL per animal). Treated SC segments of ~1 cm 
in length were dissected and immediately fixed with 4 % p-formaldehyde in PBS solution 
containing 0.1 % glutaraldehyde for 3 hrs, followed by washing with PBS and freezing in 
liquid nitrogen for the sectioning. 
 
 
2.10. Laser scanning confocal microscopy of spinal cord sections 
 
 
20 μm thick cross-sections of pre-fixed SC were prepared using a Microm HM 560 
cryostat  (Thermo  Scientific)  and  mounted  onto  pre-modified  glass  slide  for  laser 
scanning confocal microscopy (LSCM). For cell nuclei staining, glass-adhered SC 
sections were incubated with 0.3 μM DAPI in PBS for 5 min, rinsed with milli-Q water 
and dried. The samples were visualized on an Axio Observer. A1 fluorescent microscope 
and a confocal microscope Zeiss LSM 780 (Carl Zeiss) using the argon laser and 5× air 
objective. 
The quantity of rhodamine 123 delivered into the SC was assessed from LSCM images 
using ImageJ software (US National Institutes of Health). SC sections were divided into 
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4 equal quarters, and the intensity of rhodamine 123 fluorescence was quantified by 
measuring the integrated density parameter of the dorsal quarter normalized by its area in 
μm2.  At least six LSCM images per group were analyzed to  estimate the effect of 
oxidized copolymer on rhodamine 123 penetration into the spinal cord. 
Data are reported as mean ± SEM. The statistical significance between control and 
experimental groups was verified by the Wilcoxon test. The depth-dependent distribution 
of rhodamine 123 in SC sections was analyzed by measuring the fluorescence along 
diffusion direction starting from the gel-contacting site to the spinal canal with a step of 
100 μm. The criterion level for determination of statistical significance was set as p < 
 
0.05 for all comparisons. 
 
 
 
 
 
3. Results and discussion 
 
 
3.1. Characterization of oxidized copolymers 
 
 
Two glycerol-based trifunctional copolymers of EO and PO, a random copolymer 
Laprol 5003 (L5) and a block copolymer Laprol 6003 (L6) were selected as bifunctional 
pluronic analogs with enhanced ability to modulate cellular membranes [19,22]. Along 
with the primary structure, L5 and L6 copolymers differ in their number average 
molecular weight (MW), EO/PO ratio and hydrophilic lipophilic balance, HLB (Table 1). 
We showed previously that the introduction of anionic succinate moiety into different 
EO/PO copolymers in the reaction with succinic anhydride increased cellular 
compatibility and delivery properties of polymeric molecules [18,19]. In this study, 
terminal hydroxyl groups in trifunctional copolymers were directly converted into 
carboxyl groups by means of direct oxidation, and the effect of this modification was 
examined. 
The copolymers were oxidized in the reaction with CrO3  as described in the 
Experimental section. FTIR spectra of CrO3-oxidized copolymers contain a specific band 
at 1735 cm
-1 
wavenumber (Supplementary data, Fig. 1S) which corresponds to the 
carboxyl group formed during the oxidation of terminal OH. According to the acid-base 
titration, the OH conversion rate was almost 75 % for the oxidized L5 (L5–COOH) and 
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80 % for the oxidized L6 (L6–COOH), which corresponded to 2.3-2.4 modified groups 
per the trifunctional copolymer molecule. The general chemical structure of modified 
trifunctional copolymers is provided as follows, where x and y is the number of EO and 
PO units, respectively; and R: –CH2OH or –C(O)OH. 
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Additionally, Pluronic L61 (MW 2000, HLB 3) and Pluronic F68 (MW 8400, HLB 
 
29) were reacted with CrO3 to produce oxidized polymers with 67 and 68 % modification 
rate, respectively. The results show that CrO3  can be used to oxidize both random and 
block EO/PO based copolymers which differ in their HLB, MW and functionality. 
A reverse-phase HPLC analysis of the integrity of oxidized copolymers showed no 
change in the retention time for initial and modified copolymers (Supplementary data, 
Fig. 2S). This indicates that the oxidative modification by CrO3  does not result in the 
destruction of copolymer molecules. Together with a satisfactory yield, this makes the 
proposed approach useful for the synthesis of carboxyl-modified copolymers of EO and 
PO. In contrast to the reaction with succinic anhydride, which produces hydrolysable 
succinic acid ester [18,19], the oxidative modification   should provide more stable 
functionalization of copolymers as the introduced carboxyl group is not expected to 
undergo hydrolysis. 
 
 
 
3.2. Micelle-forming properties of oxidized copolymers 
 
 
The critical micellar concentration (CMC) of initial and oxidized copolymers was 
determined with the use of pyrene probe. L6 was found to have lower CMC value 
(50.9±11.8 μg/mL) in comparison with L5 (111.2±14.7 μg/mL), reflecting a relatively 
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better ability of the former copolymer to aggregate into micelles apparently due its higher 
molecular weight. Modified copolymers were characterized by statistically non- 
significant change in CMC values compared with unmodified counterparts (63.3±12 
μg/mL for L6–COOH and 98.0±7.7 μg/mL for L5–COOH). This suggests little or no 
effect of the oxidative modification of copolymers on their micelle formation. 
As reported earlier, the succinimidation of L6 and Pluronics was accompanied by a 
noticeable CMC decrease for the modified copolymers [18,19]. The results indicate that 
the esterification with succinic acid promotes copolymers aggregation in water solution 
apparently due to the increase in their MW and/or decrease in HLB, while the conversion 
of terminal OH into COOH does not significantly alter physicochemical characteristics of 
copolymers. 
Copolymer aggregates were further analyzed with the use of DLS technique in HEPES 
buffer (25 °C), where both hydrodynamic diameter and zeta potential of micelles were 
measured, and in fetal bovine serum (FBS) containing DMEM medium (37 °C) to model 
the cell culture environment. In HEPES buffer L5 and L6 copolymers appear as large 
micelles which tend to form microsized aggregates (microphase) due to their relatively 
low HLB values (Fig. 1A). 
In buffer solution oxidized copolymers were characterized by a smaller diameter and 
lower particle dispersion index (PDI) compared with unmodified ones. The average size 
of polymeric aggregates decreased in the range: L5 (330.2±4.1 nm, PDI 0.291); L6 
(303.3±7.1  nm,  PDI  0.322);  L5–COOH  (119.1±0.7  nm,  PDI  0.221);  L6–COOH 
(96.4±0.9 nm, PDI 0.155), where L6–COOH copolymer formed the micellar system with 
lowest size and dispersity (Fig. 1A). 
The electrokinetic analysis showed that initial non-ionic copolymers have slightly 
negative zeta potential of -8.1±1.1 mV for L5 and -6.1±0.3 mV for L6 attributed to the 
presence of electronegative hydroxyl groups on the surface of polymeric micelles. The 
oxidative modification of L5 and L6 copolymers resulted in a significant increase in their 
zeta potential up to -31.2±4.0 mV for L5–COOH and -24.2±4.0 mV for L6–COOH due 
to the appearance of anionic carboxyl function. 
In ‘cell culture’ conditions copolymer concentration was raised to 2 mg/mL due to the 
interference from medium components. Although increased temperature (37 °C) should 
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promote the hydrophobic interactions of EO/PO based copolymers as a result of their 
dehydratation [23], no significant increase in the diameter of copolymer aggregates was 
observed in these conditions (Fig. 1B), presumably due to a protective effect of serum 
proteins [24]. 
In DMEM/FBS modified copolymers L5–COOH and L6–COOH also formed smaller 
micelles with low PDI values near to 0.1 (Fig. 1B), which is characteristic for a mono- 
dispersed system [25]. The results demonstrate that the oxidized copolymers generate 
more stable and uniform micelles compared with unmodified counterparts, which tend to 
form microsized aggregates. Therefore, the introduction of anionic carboxyl group into 
non-ionic  copolymers  does  not  inhibit  their  micelle  formation  but  prevents  further 
micelle aggregation to the microphase. This effect is of particular interest for improving 
micellar and pharmacokinetic properties of amphiphilic copolymers of EO and PO as 
drug carriers and enhancers [24,26]. 
 
 
3.3. Effect of oxidized copolymers on cell viability and rhodamine 123 uptake 
 
 
A comparative study of cytotoxic activity of initial and modified copolymers was 
carried out with the aid of proliferative MTT-assay. Table 2 summarizes cytotoxic 
concentrations (IC50) of copolymers for primary human skin fibroblasts (HSFs) and 
neuroblastoma SH-SY5Y line used as a neuron-like model [27]. 
Unmodified L5 and L6 exhibited IC50  values for HSFs of about 0.1 and 1.4 mg/mL, 
respectively, indicating a moderate cellular toxicity in experimental conditions. 
Cytotoxicity of these copolymers was found to be significantly higher for SH-SY5Y cells 
with IC50 values of almost 6 and 24 μg/mL, respectively (Table 2). This is in accordance 
with our previous results which showed that EO/PO copolymers preferably induce death 
in cancer cells than primary fibroblasts. The observed selectivity suggests ‘intracellular 
mode’ of cytotoxicity of amphiphilic copolymers as cancer cells have more intense 
metabolism and higher proliferative potential, and therefore more readily accumulate 
copolymers in their interior [19,22]. Inside cells EO/PO copolymers were shown to 
interact with subcellular structures, including mitochondria, impairing some metabolic 
processes [28]. 
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Oxidative modification of copolymers resulted in an apparent decrease of their IC50 
values (Table 2). The increase in cytotoxicity observed for modified copolymers could be 
explained from their micelle-forming properties. As shown above, initial copolymers 
readily turn to the microphase in the culture medium (Fig. 1B), which should result in a 
significant decrease in their real concentration affecting cell viability. Modification of 
copolymers reduces their aggregation (Figs. 1A and 1B) and increases their effective 
concentration in micellar and unimer forms, which are capable of interacting with 
mammalian cells [14,23]. 
Further analysis of dose-response curves showed that oxidized copolymers exhibited 
somewhat higher cytoxicity than unmodified ones only in higher concentration range 
above 0.1 mg/mL (Fig. 2), where significant difference in copolymer aggregation was 
observed (Fig. 1). This demonstrates an importance of the aggregation state of EO/PO 
based amphiphilic polymers for their biological activity. 
Altogether, our results support that the oxidative modification of trifunctional 
copolymers does not induce an actual increase in their toxicity for human cells. However 
it is expected to increase their effective concentration and availability for biological 
interactions affecting membrane-modulating and drug delivery properties. 
An ability of copolymers to promote intracellular drug delivery was assessed on SH- 
SY5Y cells using rhodamine 123 as a pharmacological model for cellular influx and 
efflux transport [19]. Cells were incubated with rhodamine 123 in the absence or in the 
presence of copolymers as a transport enhancer, and the accumulated fluorophore was 
determined in cell lysates. The cellular uptake of rhodamine 123 alone was found to be 
relatively low, but it was significantly improved by copolymers. The promoting effect of 
copolymers increased in the range: L5, L5–COOH, L6, L6–COOH, where L6–COOH 
copolymer enhanced the intracellular accumulation of rhodamine 123 with the highest 
factor of 8.2 (Fig. 3). 
We believe that penetration enhancement of rhodamine 123 into SH-SY5Y cells by 
trifunctional copolymers could be explained by their structural similarity with membrane 
glycerolipids, which determines their high membranotropic and membrane-modulating 
activity. As shown earlier, such copolymers reversibly disturb the plasma membrane and 
increase its permeability to small molecules [19]. The introduction of carboxyl function 
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into EO/PO copolymers may enhance such an activity through different mechanisms 
[18,19], e.g. the potentiation of their effect on cellular membranes or/and the complex 
formation with a molecule transported. In contrast to tri-functional copolymers, no 
enhancing effect on rhodamine 123 transport was observed for initial and oxidized 
Pluronics L61, while Pluronic F68 somewhat inhibited cellular uptake of the fluorophore 
in the same conditions (data not shown). This indicates that above Pluronics do not 
increase permeability of the plasma membrane of SH-SY5Y cells presumably do to the 
lack in their ability to be inserted into the lipid bilayer. On the basis of above results, L6– 
COOH copolymer was chosen as a candidate for drug delivery in vivo. The oxidized 
copolymer was further examined as a drug delivery system to the spinal cord in a limited 
animal study. 
 
 
 
3.4. Topical delivery of rhodamine 123 to the spinal cord 
 
 
A rat model with exposed segments of the spinal cord after lamina bone and dura 
mater dissection was prepared as described previously [29,30]. Polyacrylate gels 
containing rhodamine 123 with and without L6–COOH copolymer were applied topically 
onto open Th13 segment for two hours. LSCM analysis of a series of cross sections of the 
SC segments after treatment with gel formulations was carried out. 
We found that rhodamine 123 alone was delivered across the SC membranes, the 
arachnoid membrane and pia matter, and appeared in different zones of white and grey 
matter (Fig. 4A). The dye penetration into the spinal cord from the gel was noticeably 
promoted by L6–COOH copolymer, which resulted in the increase of fluorescence area 
in zones adjacent to the gel-contacting site (Fig. 4B). 
The mean fluorescence of penetrated rhodamine 123 was estimated with the aid of 
ImageJ software by calculating the area-normalized integrated density in the dorsal 
quarter of SC sections in two groups. This parameter was almost 2.1-times higher in the 
experimental group, when L6–COOH copolymer was applied, compared with the control 
group (Fig. 5), indicating a noticeable promotion of the intraspinal delivery of rhodamine 
123 by the oxidized copolymer. 
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Depth-dependent distribution of rhodamine 123 in SC sections was further assessed by 
measurement of fluorescence along the diffusion direction towards the spinal canal 
(Supplementary data, Fig. 3S). An exponential decrease of intraspinal penetration of 
rhodamine 123 was observed with distance; L6–COOH enhanced the penetration depth 
over 1200 μm, and its effect was somewhat more evident in deeper layers (Fig. 3S). 
Our study demonstrates that the oxidized tri-functional copolymer of EO and PO (L6– 
COOH) promotes the delivery of model fluorophore to undamaged spinal cord tissues. 
Due to its relatively high molecular weight and micelle-forming properties, L6–COOH 
copolymer is no expected to rapidly diffuse across intact SC membranes. Therefore, the 
copolymer apparently affects the permeability of spinal cord coverings, leading to 
enhanced penetration of the probe. The glia limitans beneath the pia matter separating 
spinal cord tissues is one of the possible lipophilic barriers affected by the oxidized 
copolymer to increase the intraspinal delivery. The rupture of SC tissues upon traumatic 
injury could promote copolymer accumulation and also increase drug delivery at the 
cellular level, as shown for SH-SY5Y cells (Fig. 3). 
Further experiments should be performed to study mechanisms of the promoting effect 
of L6–COOH copolymer and its therapeutic potential for treating SC injury. Altogether, 
our  results  contribute  to  the  development  of  polymeric  systems  for  advanced  drug 
delivery into living cells and could be considered for topical treatment of acute spinal 
cord injury. 
 
 
 
 
 
4. Conclusions 
 
 
The lack of effective delivery systems for neuroprotective drugs remains a big 
challenge in treating acute neural injury. Tri-functional copolymers of ethylene oxide and 
propylene oxide appear to be a promising platform for the development of safe and 
effective drug carriers in vivo. Our results indicate that oxidative modification of these 
copolymers, which introduces the terminal carboxyl functions, significantly improves 
characteristics of polymeric micelles and promote polymer-mediated accumulation of 
fluorescent probe in neuron-like cells. For the first time we demonstrate that oxidized 
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copolymers facilitate topical delivery to the intact spinal cord tissues. The results of our 
study could potentially help to develop effective drug compositions for the treatment of 
traumatic neural injury. 
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Table 1 
 
Physicochemical characteristics of initial and oxidized trifunctional copolymers of EO 
 
and PO. 
 
 
 
 
Copolymer 
Number 
average MW 
(Da) 
Number of 
PO units per 
molecule 
Number of 
EO units per 
molecule 
 
Modification 
degree (%) 
 
 
HLB
*
 
 
L5 5000 71.9 16.7 0 6.0 
 
L5–COOH ~5000 71.9  - 75  - 
L6  6000 83.5 24.2  0 6.7 
L6–COOH ~6000 83.5 - 80 - 
 
*
HLB was calculated theoretically by the Davies method. 
 
 
 
 
 
 
 
 
 
Table 2 
 
Cytotoxic concentrations (IC50, μg/mL) of initial and modified copolymers of EO and PO 
(MTT assay). 
 
 
Copolymer 
 
HSFs 
 
SH-SY5Y cells 
 
L5 
 
L5–COOH 
L6 
L6–COOH 
 
112.7±35.2 
 
73.2±14.0 
 
1409.4±285.5 
 
393.0±38.0 
 
6.4±0.6 
 
7.4±4.3 
 
23.9±3.8 
 
15.8±8.2 
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Figure captions 
 
 
 
 
Fig. 1. Distribution of hydrodynamic diameter of initial and oxidized copolymers of EO 
and PO: (A) 50 mM HEPES, pH 7.0, temperature 25 °C, copolymer concentration 0.2 
mg/mL; (B) DMEM with 5 % FBS, temperature 37 °C, copolymer concentration 2 
mg/mL. 
Fig. 2. Dose-response curves for HSFs cultured in the presence of copolymers: (A) L5, 
L5–COOH; (B) L6, L6–COOH (MTT-assay). (□) Initial copolymers, (○) oxidized 
copolymers. 
Fig. 3. Fluorescent signal of rhodamine 123 accumulated in SH-SY5Y cells in the 
presence of initial and oxidized copolymers of PO and EO. Concentration of rhodamine - 
5 μM, copolymers - 1 mg/mL. Values are presented as mean ± SD. 
 
 
Fig. 4. Representative LSCM images of cross sections of rat spinal cord (Th13 segment) 
 
exposed to 2 % polyacrylate gel containing (A) 50 μM rhodamine 123 (control) and (B) 
 
50 μM rhodamine 123 + 5 mg/mL L6–COOH. White line confines the area of intensive 
fluorescence of rhodamine 123 at gel-contacting site. Cell nuclei are stained with DAPI. 
 
Fig. 5. Effect of oxidized copolymer L6–COOH on intraspinal penetration of rhodamine 
 
123. Area-normalized intensity was calculated using imageJ software. Values are 
presented as mean ± SEM (n = 6; p = 0.007). 
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